巴西小头畸形新生儿与奥罗普切病毒潜在垂直传播:病例系列
68份样本中6份OROV IgM阳性(5份历史病例、1份2024年病例),1例死亡婴儿脑组织等检出OROV RNA和抗原。作者认为垂直传播可能性及潜在胎儿危害须紧急调查,现有证据不完全证实垂直传播或先天畸形由OROV所致。
要点
- 68份小头畸形等先天畸形婴儿样本中6份OROV IgM阳性,其中5份为历史病例、1份为2024年病例。
- 1例死亡婴儿脑、肺、肾等组织检出OROV RNA,中枢神经系统等检出OROV抗原。
- 作者认为现有证据不完全证实垂直传播或先天畸形由OROV所致,但须紧急调查。
核心结论
- 作者在68例不明原因小头畸形新生儿中检出6例OROV IgM阳性,其中1例死亡婴儿多组织检出OROV RNA和抗原。
- 作者认为OROV垂直传播可能性及潜在胎儿危害须紧急调查,但现有证据不完全证实垂直传播或先天畸形由OROV所致。
研究设计与样本
- 共检测65例历史病例和3例2024年病例的68份样本,病例来自巴西十个州。
- 血清和脑脊液先检测梅毒、弓形虫病、风疹、巨细胞病毒、单纯疱疹、HIV、寨卡、登革和基孔肯雅,阴性者再检测OROV。
- 病原检测包括ELISA和血凝抑制试验测抗体,RT-PCR测病毒RNA。
主要发现
- 68份样本中6份OROV IgM阳性:5份为历史病例、1份为2024年病例;62份历史病例阴性,3例2024年病例均阳性。
- 阳性病例中5例女性、1例男性;并非每例均检测所有病原体,部分无母亲样本。
- 5例新生儿脑脊液和5例新生儿血清OROV IgM均阳性;5份母亲血清中4份OROV IgM阳性。
- 4份新生儿脑脊液中1份(病例6,44日龄)实时RT-qPCR OROV阳性,4份新生儿血清中0份阳性,3份母亲血清中0份阳性。
- 病例6于47日龄死亡,脑组织 macroscopic 和 microscopic 改变包括神经元、小胶质细胞和星形胶质细胞坏死与凋亡、空泡化及组织萎缩;脑、肺、肾、脑脊液和胸水检出OROV RNA,中枢神经系统、肝、肾、心、肺检出OROV抗原,主要位于神经元和小胶质细胞,也见于内皮细胞,提示血管炎。
临床怎么用
- 作者认为OROV垂直传播可能性及潜在胎儿危害须紧急调查。
- 作者认为现有证据不完全证实垂直传播或先天畸形由OROV所致,但彻底病例发现和详细调查母亲或胎儿OROV感染是优先事项。
局限性
- 并非每例均检测所有病原体,部分病例无母亲样本可用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Oropouche fever, an orthobunyavirus disease endemic in Brazilian Amazon, has caused many febrile epidemics. In 2024, an epidemic of Oropouche fever spread in Brazil, with more than 7930 cases reported between Jan 1 and Aug 31. Infections in pregnant people have suggested the possibility of negative fetal consequences, therefore we tested newborns with microcephaly for known congenital pathogens and Oropouche virus (OROV). METHODS: In this case series, we assessed historical cases of infants born with microcephaly, arthrogryposis, and other congenital malformations without a confirmed cause and their mothers for potential OROV congenital infections. The study population consisted of infants born in Brazil with samples from 2015-21 and 2024. Serum and cerebrospinal fluid (CSF) from this case series were analysed for: syphilis, toxoplasmosis, rubella, cytomegalovirus, herpes simplex, HIV, Zika, dengue, and chikungunya. Individuals that were negative for these pathogens were then tested for OROV. Pathogen testing included ELISA and haemagglutination inhibition testing for antibodies and RT-PCR for virus RNA. FINDINGS: We tested 68 samples from 65 historical cases of congential malformations and three cases from 2024. All cases were from ten states in Brazil. Three historical cases tested positive for OROV and 62 historical cases tested negative. The three cases from 2024 all tested positive for OROV. Of the positive cases, five were female and one was male. Not all pathogens were tested for each case, and some did not have maternal samples available. One of the newborns (case 6) died aged 47 days and tissue samples were tested by real-time RT-PCR, histopathology, and immunohistochemistry assays. One other newborn died in 2016 but no post-mortem samples were available. OROV IgM was detected in five of five newborn CSF samples, and five of five newborn serum samples. Four of five maternal serum samples were positive for OROV IgM. One of four newborn CSF samples (case 6 at age 44 days) was OROV positive by real-time RT-quantitative PCR and 0 of four newborn serum samples were positive, as were 0 of three maternal serum samples. Case 6 had major tissue changes of the brain macroscopically and microscopically, including necrotic and apoptotic changes of neurons, microglia and astrocytes, vacuolisation, and tissue atrophy. OROV RNA was detected in brain, lungs, kidney, CSF, and pleural fluid; OROV antigens were found in CNS, liver, kidney, heart, and lung, mainly in neurons and microglia and also in endothelial cells, suggesting vasculitis. INTERPRETATION: We detected OROV IgM in six of 68 newborns with microcephaly of unknown cause. One infant who died had OROV RNA and antigen in several tissues, including the brain. The possibility of OROV vertical transmission and potential fetal harm must be investigated with urgency. The evidence presented here does not completely confirm vertical transmission or congenital malformations due to OROV, but thorough case finding and detailed investigation of maternal or fetal OROV infection is a priority. FUNDING: Evandro Chagas Institute, Secretaria de Vigilância em Saúde e Ambiente, and Ministry of Health and National Institute of Science and Technology for Emerging and Reemerging Viruses.
引用
- das Neves Martins FE, Chiang JO, Nunes BTD, et al. Newborns with microcephaly in Brazil and potential vertical transmission of Oropouche virus: a case series. Lancet Infect Dis. 2024. PMID: 39423837. doi:10.1016/S1473-3099(24)00617-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。